Rocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner

Zacks Jan 15 08:40 ET

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), CareDx (CDNA) and Intellia Therapeutics (NTLA)

TipRanksJan 14 06:30 ET · Ratings

J.P. Morgan Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Cuts Target Price to $48

Moomoo NewsJan 8 08:30 ET · Ratings

Rocket Pharmaceuticals Price Target Lowered to $48 From $49 at JPMorgan

TipRanksJan 8 07:40 ET

Wedbush Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Maintains Target Price $32

Moomoo NewsJan 6 08:34 ET · Ratings

Buy Recommendation for Rocket Pharmaceuticals: Promising Potential of RP-L301 in Severe PKD Cases

TipRanksJan 6 08:25 ET